Bio Historical Financial Ratios
| BIO Stock | USD 243.31 3.85 1.56% |
Bio Rad is presently reporting on over 114 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 2.13 or Days Sales Outstanding of 87.31 will help investors to properly organize and evaluate Bio Rad Laboratories financial condition quickly.
Bio |
About Bio Financial Ratios Analysis
Bio Rad LaboratoriesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Bio Rad investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Bio financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Bio Rad history.
Bio Rad Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Bio Rad Laboratories stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Bio Rad sales, a figure that is much harder to manipulate than other Bio Rad Laboratories multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most ratios from Bio Rad's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Bio Rad Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Bio Rad's Stock Based Compensation To Revenue is very stable compared to the past year. As of the 28th of March 2025, PB Ratio is likely to grow to 2.13, while Capex To Depreciation is likely to drop 1.40.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 64.43 | 66.82 | 76.84 | 87.31 | PTB Ratio | 1.3 | 1.08 | 1.41 | 2.13 |
Bio Rad fundamentals Correlations
Click cells to compare fundamentals
Bio Rad Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bio Rad fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 6.82 | 7.71 | 4.47 | 3.53 | 3.61 | 3.79 | |
| Ptb Ratio | 1.76 | 1.65 | 1.3 | 1.08 | 1.41 | 2.13 | |
| Days Sales Outstanding | 60.14 | 52.9 | 64.43 | 66.82 | 76.84 | 87.31 | |
| Book Value Per Share | 331.9 | 458.15 | 322.82 | 299.26 | 232.84 | 244.48 | |
| Free Cash Flow Yield | 0.0275 | 0.0238 | 0.006411 | 0.0231 | 0.0287 | 0.0302 | |
| Operating Cash Flow Per Share | 19.33 | 22.01 | 6.53 | 12.84 | 16.13 | 16.94 | |
| Stock Based Compensation To Revenue | 0.0154 | 0.0163 | 0.0175 | 0.0217 | 0.0229 | 0.0207 | |
| Capex To Depreciation | 0.72 | 0.9 | 0.83 | 1.25 | 1.43 | 1.4 | |
| Pb Ratio | 1.76 | 1.65 | 1.3 | 1.08 | 1.41 | 2.13 | |
| Ev To Sales | 6.56 | 7.55 | 4.74 | 3.91 | 3.68 | 3.86 | |
| Free Cash Flow Per Share | 16.0 | 17.96 | 2.7 | 7.47 | 9.44 | 9.91 | |
| Roic | 0.0257 | 0.0223 | 0.0287 | 0.0214 | 0.0329 | 0.0313 | |
| Net Income Per Share | 128.13 | 142.61 | (121.79) | (21.82) | (65.36) | (62.1) | |
| Days Of Inventory On Hand | 205.02 | 162.94 | 212.61 | 228.95 | 206.06 | 148.81 | |
| Payables Turnover | 9.86 | 7.94 | 9.03 | 9.14 | 8.6 | 9.71 | |
| Research And Ddevelopement To Revenue | 0.0877 | 0.089 | 0.093 | 0.0917 | 0.0926 | 0.0763 | |
| Capex To Revenue | 0.0389 | 0.0413 | 0.0407 | 0.0587 | 0.0736 | 0.0701 | |
| Cash Per Share | 33.48 | 29.35 | 60.31 | 55.02 | 41.7 | 43.78 | |
| Pocfratio | 30.16 | 34.33 | 64.41 | 25.15 | 20.36 | 15.2 | |
| Interest Coverage | 18.8 | 315.56 | 12.66 | 6.83 | 5.5 | 5.23 | |
| Capex To Operating Cash Flow | 0.22 | 0.17 | 0.18 | 0.59 | 0.42 | 0.39 | |
| Pfcf Ratio | 36.42 | 42.07 | 155.99 | 43.21 | 34.82 | 36.56 | |
| Days Payables Outstanding | 45.95 | 40.42 | 39.91 | 42.42 | 37.59 | 58.42 | |
| Ev To Operating Cash Flow | 23.63 | 29.04 | 33.63 | 68.34 | 27.83 | 17.38 | |
| Pe Ratio | 4.55 | 5.3 | (3.45) | (14.8) | (5.03) | (4.77) | |
| Return On Tangible Assets | 0.31 | 0.25 | (0.28) | (0.0551) | (0.21) | (0.2) | |
| Ev To Free Cash Flow | 35.06 | 41.22 | 165.5 | 47.8 | 35.47 | 37.25 | |
| Earnings Yield | 0.22 | 0.19 | (0.29) | (0.0676) | (0.2) | (0.19) | |
| Intangibles To Total Assets | 0.0379 | 0.0338 | 0.0547 | 0.0597 | 0.0752 | 0.14 | |
| Net Debt To E B I T D A | (0.13) | (0.0817) | (0.17) | (1.65) | (0.0814) | (0.0773) | |
| Current Ratio | 3.39 | 2.92 | 5.55 | 5.83 | 2.58 | 2.3 | |
| Tangible Book Value Per Share | 315.39 | 438.0 | 298.02 | 274.13 | 207.88 | 218.28 | |
| Receivables Turnover | 6.07 | 6.9 | 5.67 | 5.46 | 4.92 | 3.78 | |
| Shareholders Equity Per Share | 331.9 | 458.15 | 322.82 | 299.26 | 232.84 | 244.48 | |
| Debt To Equity | 0.001423 | 8.05E-4 | 0.12 | 0.16 | 0.0265 | 0.0252 | |
| Capex Per Share | 3.32 | 4.05 | 3.83 | 5.36 | 6.7 | 7.03 |
Pair Trading with Bio Rad
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.Moving together with Bio Stock
Moving against Bio Stock
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.412 | Earnings Share (65.84) | Revenue Per Share | Quarterly Revenue Growth (0.02) | Return On Assets |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.